Join us at the Olink Proteomics Conference, a novel platform for scientists exploring the latest advancements in proteomics and proteogenomics on immunology, oncology, neuroscience, ageing, inflammation and more applications.
This digital event features presentations from esteemed scientists and provides a platform to connect with peers, identify potential collaborations and dive into advanced protein biomarkers’ discovery tools and results.
The invitation is for a 5-hour event, with 2.5 hours dedicated to live sessions, while other sections like the virtual booth will remain open for the full duration
The agenda includes 3 tracks covering:
Drug Discovery
Gain insights into disease mechanisms and hear about pipeline efficiencies achieved with Olink solutions in drug development, patients’ stratifications, and clinical trials. This track includes a session where cohorts leaders from across the world will share information about their Samples collections.
Biomarker Discovery / Clinical Translation
Identify actionable protein biomarkers to reduce the gap between genotype and phenotype.
Multiomics and Proteogenomics
Join the discussion on disease risk prediction with polygenic and proteins risk scoring in the aging population.
Register now for free to engage with cutting-edge proteomics research, network with peers and interact with Olink staff. The event will be live twice, first for EMEA+APAC time zone and second for AMR time zones, as indicated in the agenda below. You are free to attend at any time, just select the preferred placeholder for your calendar.
Want to share your proteomics findings, spark discussions, and connect with fellow experts in our digital poster hall?
Click Here to submit a poster abstract by September 10th, 2024
Olink is the proud sponsor of this event, with the support of Formulatrix, Hamilton and SPT Labtech.
Drug Discovery Track Agenda
Biomarker Discovery / Clinical Translation Track Agenda
Multiomics & Proteogenomic Track Agenda
Sr Director, Population Health
Olink Proteomics
Director, Neuroscience Data Science (J&J)
Dr. Med DeCode Genetics
Vice Executive Director and Group Leader of the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) and professor at the University of Copenhagen
Senior Vice President - Biomarker R&D- Octave Bioscience
PhD, pharmacist and junior researcher in tumor immunology
Professor of Biochemistry and Director of the Proteomics Core, Weill Cornell Medicine, Qatar
Research Professor of Life Science and the Director of HKUST-Shanghai Sixth People's Hospital Joint Research Center for Brain Science.
Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Genetics and Epidemiology at Joslin Diabetes Center in Boston, MA.
St. Cross Chair Epidemiology, Nuffield Department of Population Health (NDPH), University of Oxford
Principal Investigator in the Massachusetts General Hospital Center for Cancer Research and a faculty member at Harvard Medical School
degree in Molecular Biology, worked in Neuroscience and Oncology lab roles
Ph.D., MBA, Product and Marketing Senior Director, Novogene AMEA (Asia Pacific, Middle East & Africa)
Chief Scientific Officer and Vice President Global Operations, Laboratory Services at Sampled
Research Professor of Medicine, Vanderbilt University Medical Center
Chief Data and Analytics Officer